Developments in treatment of anxiety disorders: Psychotherapy, pharmacotherapy, and psychosurgery

Depression and Anxiety

Volumn 19, Issue 2, 2004, Pages 63-76

  Balon, Richard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; ABERCARNIL; ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROFAROMINE; CARBON DIOXIDE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; FLUOXETINE; HYDROXYZINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NEUROTRANSMITTER; PAROXETINE; PHENELZINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRAPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VENLAFAXINE XR;

ACUTE STRESS DISORDER; ALTERNATIVE MEDICINE; ANOREXIA; ANXIETY DISORDER; ASTHENIA; BEHAVIOR THERAPY; BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; CONTROLLED DRUG RELEASE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; EJACULATION DISORDER; FOLLOW UP; FRONTAL LOBE; GASTROINTESTINAL SYMPTOM; HEALTH INSURANCE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; INCREASED APPETITE; INSOMNIA; IRRITABILITY; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; ORGASM DISORDER; OUTCOMES RESEARCH; PANIC; PATIENT CARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; PSYCHOSURGERY; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PHOBIA; SOMNOLENCE; SURGICAL TECHNIQUE; THERMOCAPSULOTOMY; VISUAL IMPAIRMENT; WEIGHT GAIN; XEROSTOMIA;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BRAIN; DEPRESSIVE DISORDER; HUMANS; PSYCHOSURGERY; RANDOMIZED CONTROLLED TRIALS;

EID: 1642350059     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.10149     Document Type: Review

References (19)

1. Basoglu M, Livanou M, Salcioglu E, Kalender D. 2003. A brief behavioural treatment of chronic post-traumatic stress disorder in earthquake survivors: Results from an open clinical trial. Psychol Med 33:647-654.
2. Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R. 1999. Treating acute stress disorder: An evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychother 156:1780-1786.
3. Cottraux J, Note I, Albuisson E, Yao SN, Note B, Mollard E, Bonasse F, Jalenques I, Guerin J, Coudert AJ. 2000. Cognitive behavior therapy versus supportive therapy in social phobia: A randomized controlled trial. Psychother Psychosom 69:137-146.
4. Davidson JRT, Weisler RH, Butterfield MI, Casat CD, Connor KM, Barnett S, van Meter S. 2003. Mirtazapine vs. placebo in posttraumatic stress disorder: A pilot trial. Biol Psychiatry 53:188-191.
5. Davis LL, Nugent AL, Murray J, Kramer GL, Petty F. 2000. Nefazodone treatment for chronic posttraumatic stress disorder: An open trial. J Clin Psychopharmacol 20:159-164.
6. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. 2000. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder. A 6-month randomized trial. JAMA 283:3082-3088.
7. Goisman RM, Warshaw MG, Keller MB. 1999. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia. Am J Psychiatry 156:1819-1821.
8. Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JRT. 2002. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder. Ann Clin Psychiatry 14:215-221.
9. Kampman M, Keijsers GPJ, Hoogduin CAL, Hendriks G-J. 2002. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. J Clin Psychiatry 63:772-777.
10. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, Eisenberg DM. 2001. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158:289-294.
11. Lipsitz JD, Markowitz JC, Cherry S, Fyer AJ. 1999. Open trial of interpersonal psychotherapy for the treatment of social phobia. Am J Psychiatry 156:1814-1816.
12. Marks IM, O'Dwyer AM, Meehan O, Greist J, Baer L, McGuire P. 2000. Subjective imagery in obsessive-compulsive disorder before and after exposure therapy. Br J Psychiatry 176:387-391.
13. Nardi AE, Valenca AM, Nascimento I, Mezzasalma MA, Zin WA. 2000. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. Psychiatry Res 94:179-184.
14. Pande AC, Greiner M, Adams JB, Lydiard RB, Pierce MW. 1999. Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder. Biol Psychiatry 46:860-862.
15. Rickels K, Pollack MH, Sheehan DV, Haskins JT. 2000a. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 157:968-974.
16. Rickels K, DeMartinis N, Aufdembrinke B. 2000b. A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder. J Clin Psychopharmacol 20:12-18.
17. Rief W, Trenkamp S, Auer S, Fichter M. 2000. Cognitive behavior therapy in panic disorder and comorbid depression. Psychother Psychosomat 69:70-78.
18. Ruck C, Andreewitch S, Flyckt K, Edman G, Nyman H, Meyerson BA, Lippitz BE, Hindmarsh T, Svanborg P, Mindus P, Asberg M. 2003. Capsulotomy for refractory anxiety disorders: Long-term follow-up of 26 patients. Am J Psychiatry 160:513-521.
19. Shear MK, Houck P, Greeno C, Masters S. 2001. Emotion-focused psychotherapy for patients with panic disorder. Am J Psychiatry 158:1993-1998.